Success Metrics

Clinical Success Rate

85.7%

Based on 6 completed trials

Completion Rate

86%(6/7)

Active Trials

1(13%)

Results Posted

50%(3 trials)

Terminated

1(13%)

Phase Distribution

Ph phase_1

38%

Ph phase_2

38%

Ph not_applicable

13%

Ph early_phase_1

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Early Phase 1First-in-human

1(12.5%)

Phase 1Safety & dosage

3(37.5%)

Phase 2Efficacy & side effects

3(37.5%)

N/ANon-phased studies

1(12.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(6)

Terminated(1)

Detailed Status

Completed6

Active, not recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

85.7%

Most Advanced

Phase 2

Trials by Phase

Early Phase 11 (12.5%)

Phase 13 (37.5%)

Phase 23 (37.5%)

N/A1 (12.5%)

Trials by Status

active_not_recruiting113%

completed675%

terminated113%

Recent Activity

1 active trials

Showing 5 of 8

active_not_recruitingphase_2

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

NCT06790290

completedphase_2

A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults

NCT03529773

terminatedphase_2

A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

NCT03572062

completedearly_phase_1

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults

NCT03718390

completedphase_1

Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants

NCT02426632

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT06790290Phase 2

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

Active Not Recruiting

NCT03529773Phase 2

A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults

Completed

NCT03572062Phase 2

A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

Terminated

NCT03718390Early Phase 1

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults

Completed

NCT02426632Phase 1

Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants

Completed

NCT00848744Not Applicable

Comparison of Two Salicylic Acid Formulations

Completed

NCT00495274Phase 1

Bioequivalence and Food Effect Study in Healthy Volunteers

Completed

NCT00548769Phase 1

Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients

Completed

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8